세계 신경인지 평가 및 재활 시장 : 규모, 점유율, 동향 분석 보고서 - 구성별, 제공업체별, 지역별 전망 및 예측(2023-2030년)

Global Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component (Neurorehabilitation Therapy, and Neurocognitive Assessment Testing), By Providers, By Regional Outlook and Forecast, 2023 - 2030

US $ 3,600 ￦ 5,166,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 6,200,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,680,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 신경인지 평가와 재활 시장 규모는 2030년까지 236억 달러에 이르고, 예측기간 동안 CAGR 8.4%로 확대될 것으로 예측됩니다.

게다가, 팬데믹 기간 동안 원격 의료 솔루션의 급속한 보급이 있었습니다. 신경인지 평가와 재활 서비스는 가상 플랫폼으로 이동하여 의료 제공업체는 원격 케어를 계속할 수 있게 되었습니다. 유행은 스트레스, 불안, 우울증 증가 등 정신 건강 문제에 대한 인식을 높였습니다. 이러한 정신 건강에 대한 관심은 종합적인 정신 건강 평가에 신경인지 평가를 포함시키는 중요성을 강조했습니다. 시장은 전반적인 정신 의료의 필수 요소로 인지적 웰빙에 종사하는 방향으로 이동을 경험했습니다. 따라서 유행은 시장에 긍정적인 영향을 미쳤습니다.

그러나 신경인지 평가와 재활 서비스는 고액이기 때문에 특히 저소득층이나 의료 자원이 한정되어 있는 지역의 사람들에게는 이용의 용이성이 제한될 가능성이 있습니다. 게다가, 고가의 비용은 신경인지 관리의 제공에 있어서 불평등을 조장할 수 있습니다. 부유한 사람들과 보험에 가입한 사람들은 고급 평가와 재활 서비스를 보다 이용하기 쉽고 기존 의료 격차를 악화시킬 수 있습니다. 위의 요인으로 인해 향후 몇 년동안 시장 성장이 저해 될 것으로 보입니다.

구성 전망

구성별로 시장은 신경인지 평가 검사와 신경 재활 요법으로 구분됩니다. 신경인지 평가 검사 부문은 2022년 시장에서 상당한 수익 점유율을 획득했습니다. 신경인지 평가는 종종 작업치료사, 언어치료사, 신경학자, 신경심리학자의 협력을 필요로 합니다. 이 학제적인 기법을 도입하면 개인의 인지적 행복을 철저히 이해할 수 있습니다. 경우에 따라 정서와 성격 기능 평가도 포함됩니다. 이것은 인지 장애가 감정적 행복에 미치는 영향을 이해하는 데 도움이 됩니다.

제공업체의 전망

제공업체별로 보면, 시장은 재활센터, 병원 및 진료소, 재택 케어 환경, 물리치료 센터로 세분화됩니다. 홈 케어 부문은 시장에서 큰 수익 점유율을 받고 있습니다. 이는 간병인의 편의성, 예방 케어의 중시, 맞춤 치료 계획, 유행 관련 변화, 기술 통합의 개선 등으로 가정에서의 신경인지 평가에 대한 수요가 증가하고 있기 때문입니다. 재택 신경인지 케어는 감정적, 심리 사회적 측면에 대처하는 중요성을 인식하고 있습니다. 인지 기능 장애로 인한 감정적 문제를 해결하기 위해 원격 의료 상담 세션 및 지원 그룹을 준비 할 수 있습니다.

지역 전망

지역별로 볼 때 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 아프리카에서 분석됩니다. 2022년에는 북미가 시장에서 가장 큰 수익 점유율을 기록했습니다. 이는 의료 부문의 연구개발이 중요하기 때문입니다. 이 지역은 연구기관, 의료계 대학, 민간 기업에 의한 견고한 생태계가 구축되어 신경인지 기술의 지속적인 혁신이 촉진될 것으로 기대되고 있습니다. 게다가 학술계와 의료업계와의 연계는 선진적인 평가·재활 툴의 신속한 개발과 도입을 촉진합니다.

목차

제1장 시장 범위와 조사 방법

• 시장의 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요람

• 주요 하이라이트

제3장 시장 개요

• 소개
  • 개요
    • 시장구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• Porter's Five Forces 분석

제4장 세계 시장 : 구성별

• 세계 신경 재활 요법 시장 : 지역별
• 세계 신경인지 평가 검사 시장 : 지역별

제5장 세계 시장 : 제공업체별

• 세계 재활센터 시장 : 지역별
• 세계 병원 및 진료소 시장 : 지역별
• 세계 재택 케어 환경 시장 : 지역별
• 세계 물리치료 센터 시장 : 지역별

제6장 세계 시장 : 지역별

• 북미
  • 북미 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 싱가포르
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카, 중동 및 아프리카
  • 라틴아메리카, 중동 및 아프리카 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트(UAE)
    • 사우디아라비아
    • 남아프리카
    • 나이지리아
    • 기타 라틴아메리카, 중동 및 아프리카

제7장 기업 프로파일

• Cambridge Cognition Holdings PLC
• Cognifit, Inc
• Cogstate Ltd
• Lumos Labs, Inc(Lumosity)
• CNS Vital Signs, LLC
• Posit Science Corporation
• BrainCheck, Inc
• Constant Therapy Health
• NeuronUP SL
• SCHUHFRIED GmbH

제8장 신경인지 평가와 재활시장의 성공 필수조건

JHS

영문 목차

영문목차

The Global Neurocognitive Assessment And Rehabilitation Market size is expected to reach $23.6 billion by 2030, rising at a market growth of 8.4% CAGR during the forecast period.

The rising number of senior people and the growing incidence of neurological disorders mainly drive the market in Asia Pacific. Countries such as China, Japan, South Korea, and India are expected to grow considerably over the forecast period. Consequently, the Asia Pacific region would acquire nearly 25% of the total market share by 2030. Cultural attitudes towards mental health and neurological conditions vary widely in the Asia Pacific region. Initiatives should focus on increasing awareness, reducing stigma, and promoting cultural sensitivity regarding neurocognitive health. Some of the factors impacting the market are increasing prevalence of neurological disorders, growing technology advancement in neurocognitive rehabilitation and high cost of technologies and services.

With the increasing awareness of neurological disorders, there is a growing focus on early detection and intervention. Neurocognitive assessment is crucial in identifying cognitive deficits early, allowing for timely and targeted rehabilitation interventions. The surge in neurological disorders has prompted increased research initiatives focused on understanding the underlying mechanisms, hazard factors, and potential interventions. This research contributes to the development of evidence-based assessment tools and rehabilitation strategies. Thus, the increasing number of neurological diseases is a key driver positively influencing the growth of the market. Additionally, advanced neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), enable more precise and detailed brain structure and function assessment. VR and AR technologies have been incorporated into neurocognitive rehabilitation programs. These immersive technologies create realistic environments for cognitive exercises and rehabilitation activities. Therefore, the growing technological advancement is a driving force behind expanding the market.

Moreover, During the pandemic, there was a rapid and widespread adoption of telehealth solutions. Neurocognitive assessments and rehabilitation services transitioned to virtual platforms, allowing healthcare providers to continue delivering care remotely. The pandemic heightened awareness of mental health challenges, including increased stress, anxiety, and depression. This focus on mental health underscored the importance of including neurocognitive assessments in comprehensive mental health evaluations. The market witnessed a shift toward addressing cognitive well-being as an integral component of overall mental health care. Therefore, the pandemic positively impacted the market.

However, the high cost of neurocognitive assessment technologies and rehabilitation services can limit accessibility, particularly for individuals in lower-income brackets or regions with limited healthcare resources. Moreover, the high cost can contribute to inequality in the delivery of neurocognitive care. Affluent individuals or those with better insurance coverage may have greater access to advanced assessments and rehabilitation services, exacerbating existing healthcare disparities. Due to the above factors, the market growth will be hampered in the coming years.

Component Outlook

On the basis of component, the market is segmented into neurocognitive assessment testing and neurorehabilitation therapy. The neurocognitive assessment testing segment acquired a substantial revenue share in the market in 2022. Neurocognitive evaluations often require the cooperation of occupational therapists, speech therapists, neurologists, and neuropsychologists. Implementing this interdisciplinary methodology assures a thorough comprehension of the cognitive well-being of the individual. In some cases, assessments may include measures of emotional and personality functioning. This helps in understanding the impact of cognitive impairments on emotional well-being.

Provider Outlook

Based on providers, the market is fragmented into rehab centers, hospital & clinics, homecare settings, and physiotherapy centers. The homecare settings segment garnered a significant revenue share in the market. This can be attributed to the increasing demand for in-home neurocognitive assessments driven by convenience for caregivers, preventive care focus, individualized treatment plans, pandemic-related changes, and improved technology integration. Home-based neurocognitive care recognizes the importance of addressing emotional and psychosocial aspects. Telehealth counseling sessions and support groups can be arranged to help individuals cope with the emotional challenges associated with cognitive impairment.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the largest revenue share in the market. This can be attributed to a strong emphasis on research & development in the healthcare sector. The region's robust ecosystem of research institutions, medical universities, and private industry players is expected to foster continuous innovation in neurocognitive technologies. Moreover, collaborations between academia and the healthcare industry facilitate the rapid development and adoption of advanced assessment & rehabilitation tools.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH

Scope of the Study

Market Segments covered in the Report:

By Component

• Neurorehabilitation Therapy
• Neurocognitive Assessment Testing

By Providers

• Rehab Centers
• Hospital & Clinics
• Homecare Settings
• Physiotherapy Centers

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Cambridge Cognition Holdings plc
• Cognifit, Inc.
• Cogstate Ltd.
• Lumos Labs, Inc. (Lumosity)
• CNS Vital Signs, LLC
• Posit Science Corporation
• BrainCheck, Inc.
• Constant Therapy Health
• NeuronUP SL
• SCHUHFRIED GmbH

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Neurocognitive Assessment And Rehabilitation Market, by Component
  • 1.4.2 Global Neurocognitive Assessment And Rehabilitation Market, by Providers
  • 1.4.3 Global Neurocognitive Assessment And Rehabilitation Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter's Five Forces Analysis

Chapter 4. Global Neurocognitive Assessment And Rehabilitation Market by Component

• 4.1 Global Neurorehabilitation Therapy Market by Region
• 4.2 Global Neurocognitive Assessment Testing Market by Region

Chapter 5. Global Neurocognitive Assessment And Rehabilitation Market by Providers

• 5.1 Global Rehab Centers Market by Region
• 5.2 Global Hospital & Clinics Market by Region
• 5.3 Global Homecare Settings Market by Region
• 5.4 Global Physiotherapy Centers Market by Region

Chapter 6. Global Neurocognitive Assessment And Rehabilitation Market by Region

• 6.1 North America Neurocognitive Assessment And Rehabilitation Market
  • 6.1.1 North America Neurocognitive Assessment And Rehabilitation Market by Component
    • 6.1.1.1 North America Neurorehabilitation Therapy Market by Country
    • 6.1.1.2 North America Neurocognitive Assessment Testing Market by Country
  • 6.1.2 North America Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.1.2.1 North America Rehab Centers Market by Country
    • 6.1.2.2 North America Hospital & Clinics Market by Country
    • 6.1.2.3 North America Homecare Settings Market by Country
    • 6.1.2.4 North America Physiotherapy Centers Market by Country
  • 6.1.3 North America Neurocognitive Assessment And Rehabilitation Market by Country
    • 6.1.3.1 US Neurocognitive Assessment And Rehabilitation Market
      • 6.1.3.1.1 US Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.1.3.1.2 US Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.1.3.2 Canada Neurocognitive Assessment And Rehabilitation Market
      • 6.1.3.2.1 Canada Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.1.3.2.2 Canada Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.1.3.3 Mexico Neurocognitive Assessment And Rehabilitation Market
      • 6.1.3.3.1 Mexico Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.1.3.3.2 Mexico Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.1.3.4 Rest of North America Neurocognitive Assessment And Rehabilitation Market
      • 6.1.3.4.1 Rest of North America Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.1.3.4.2 Rest of North America Neurocognitive Assessment And Rehabilitation Market by Providers
• 6.2 Europe Neurocognitive Assessment And Rehabilitation Market
  • 6.2.1 Europe Neurocognitive Assessment And Rehabilitation Market by Component
    • 6.2.1.1 Europe Neurorehabilitation Therapy Market by Country
    • 6.2.1.2 Europe Neurocognitive Assessment Testing Market by Country
  • 6.2.2 Europe Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.2.2.1 Europe Rehab Centers Market by Country
    • 6.2.2.2 Europe Hospital & Clinics Market by Country
    • 6.2.2.3 Europe Homecare Settings Market by Country
    • 6.2.2.4 Europe Physiotherapy Centers Market by Country
  • 6.2.3 Europe Neurocognitive Assessment And Rehabilitation Market by Country
    • 6.2.3.1 Germany Neurocognitive Assessment And Rehabilitation Market
      • 6.2.3.1.1 Germany Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.2.3.1.2 Germany Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.2.3.2 UK Neurocognitive Assessment And Rehabilitation Market
      • 6.2.3.2.1 UK Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.2.3.2.2 UK Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.2.3.3 France Neurocognitive Assessment And Rehabilitation Market
      • 6.2.3.3.1 France Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.2.3.3.2 France Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.2.3.4 Russia Neurocognitive Assessment And Rehabilitation Market
      • 6.2.3.4.1 Russia Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.2.3.4.2 Russia Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.2.3.5 Spain Neurocognitive Assessment And Rehabilitation Market
      • 6.2.3.5.1 Spain Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.2.3.5.2 Spain Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.2.3.6 Italy Neurocognitive Assessment And Rehabilitation Market
      • 6.2.3.6.1 Italy Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.2.3.6.2 Italy Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.2.3.7 Rest of Europe Neurocognitive Assessment And Rehabilitation Market
      • 6.2.3.7.1 Rest of Europe Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.2.3.7.2 Rest of Europe Neurocognitive Assessment And Rehabilitation Market by Providers
• 6.3 Asia Pacific Neurocognitive Assessment And Rehabilitation Market
  • 6.3.1 Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Component
    • 6.3.1.1 Asia Pacific Neurorehabilitation Therapy Market by Country
    • 6.3.1.2 Asia Pacific Neurocognitive Assessment Testing Market by Country
  • 6.3.2 Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.3.2.1 Asia Pacific Rehab Centers Market by Country
    • 6.3.2.2 Asia Pacific Hospital & Clinics Market by Country
    • 6.3.2.3 Asia Pacific Homecare Settings Market by Country
    • 6.3.2.4 Asia Pacific Physiotherapy Centers Market by Country
  • 6.3.3 Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Country
    • 6.3.3.1 China Neurocognitive Assessment And Rehabilitation Market
      • 6.3.3.1.1 China Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.3.3.1.2 China Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.3.3.2 Japan Neurocognitive Assessment And Rehabilitation Market
      • 6.3.3.2.1 Japan Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.3.3.2.2 Japan Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.3.3.3 India Neurocognitive Assessment And Rehabilitation Market
      • 6.3.3.3.1 India Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.3.3.3.2 India Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.3.3.4 South Korea Neurocognitive Assessment And Rehabilitation Market
      • 6.3.3.4.1 South Korea Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.3.3.4.2 South Korea Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.3.3.5 Singapore Neurocognitive Assessment And Rehabilitation Market
      • 6.3.3.5.1 Singapore Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.3.3.5.2 Singapore Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.3.3.6 Malaysia Neurocognitive Assessment And Rehabilitation Market
      • 6.3.3.6.1 Malaysia Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.3.3.6.2 Malaysia Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.3.3.7 Rest of Asia Pacific Neurocognitive Assessment And Rehabilitation Market
      • 6.3.3.7.1 Rest of Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.3.3.7.2 Rest of Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Providers
• 6.4 LAMEA Neurocognitive Assessment And Rehabilitation Market
  • 6.4.1 LAMEA Neurocognitive Assessment And Rehabilitation Market by Component
    • 6.4.1.1 LAMEA Neurorehabilitation Therapy Market by Country
    • 6.4.1.2 LAMEA Neurocognitive Assessment Testing Market by Country
  • 6.4.2 LAMEA Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.4.2.1 LAMEA Rehab Centers Market by Country
    • 6.4.2.2 LAMEA Hospital & Clinics Market by Country
    • 6.4.2.3 LAMEA Homecare Settings Market by Country
    • 6.4.2.4 LAMEA Physiotherapy Centers Market by Country
  • 6.4.3 LAMEA Neurocognitive Assessment And Rehabilitation Market by Country
    • 6.4.3.1 Brazil Neurocognitive Assessment And Rehabilitation Market
      • 6.4.3.1.1 Brazil Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.4.3.1.2 Brazil Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.4.3.2 Argentina Neurocognitive Assessment And Rehabilitation Market
      • 6.4.3.2.1 Argentina Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.4.3.2.2 Argentina Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.4.3.3 UAE Neurocognitive Assessment And Rehabilitation Market
      • 6.4.3.3.1 UAE Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.4.3.3.2 UAE Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.4.3.4 Saudi Arabia Neurocognitive Assessment And Rehabilitation Market
      • 6.4.3.4.1 Saudi Arabia Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.4.3.4.2 Saudi Arabia Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.4.3.5 South Africa Neurocognitive Assessment And Rehabilitation Market
      • 6.4.3.5.1 South Africa Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.4.3.5.2 South Africa Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.4.3.6 Nigeria Neurocognitive Assessment And Rehabilitation Market
      • 6.4.3.6.1 Nigeria Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.4.3.6.2 Nigeria Neurocognitive Assessment And Rehabilitation Market by Providers
    • 6.4.3.7 Rest of LAMEA Neurocognitive Assessment And Rehabilitation Market
      • 6.4.3.7.1 Rest of LAMEA Neurocognitive Assessment And Rehabilitation Market by Component
      • 6.4.3.7.2 Rest of LAMEA Neurocognitive Assessment And Rehabilitation Market by Providers

Chapter 7. Company Profiles

• 7.1 Cambridge Cognition Holdings PLC
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental and Regional Analysis
  • 7.1.4 Research & Development Expenses
  • 7.1.5 Recent strategies and developments:
    • 7.1.5.1 Partnerships, Collaborations, and Agreements:
    • 7.1.5.2 Product Launches and Product Expansions:
    • 7.1.5.3 Acquisition and Mergers:
  • 7.1.6 SWOT Analysis
• 7.2 Cognifit, Inc.
  • 7.2.1 Company Overview
• 7.3 Cogstate Ltd.
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Segmental and Regional Analysis
  • 7.3.4 SWOT Analysis
• 7.4 Lumos Labs, Inc. (Lumosity)
  • 7.4.1 Company Overview
  • 7.4.2 SWOT Analysis
• 7.5 CNS Vital Signs, LLC
  • 7.5.1 Company Overview
  • 7.5.2 SWOT Analysis
• 7.6 Posit Science Corporation
  • 7.6.1 Company Overview
  • 7.6.2 SWOT Analysis
• 7.7 BrainCheck, Inc.
  • 7.7.1 Company Overview
  • 7.7.2 SWOT Analysis
• 7.8 Constant Therapy Health
  • 7.8.1 Company Overview
  • 7.8.2 Recent strategies and developments:
    • 7.8.2.1 Trials and Approvals:
  • 7.8.3 SWOT Analysis
• 7.9 NeuronUP SL
  • 7.9.1 Company Overview
  • 7.9.2 SWOT Analysis
• 7.10. SCHUHFRIED GmbH
  • 7.10.1 Company Overview
  • 7.10.2 SWOT Analysis

Chapter 8. Winning Imperatives of Neurocognitive Assessment and Rehabilitation Market

관련자료